Phreesia Financials

PHR Stock  USD 19.87  0.87  4.58%   
Based on the key measurements obtained from Phreesia's financial statements, Phreesia may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At this time, Phreesia's Common Stock Total Equity is relatively stable compared to the past year. As of 11/22/2024, Capital Surpluse is likely to grow to about 1.1 B, while Other Current Liabilities is likely to drop slightly above 37.6 M. Key indicators impacting Phreesia's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio2.521.777
Significantly Up
Slightly volatile
The essential information of the day-to-day investment outlook for Phreesia includes many different criteria found on its balance sheet. An individual investor should monitor Phreesia's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Phreesia.

Cash And Equivalents

148.8 Million

  
Understanding current and past Phreesia Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Phreesia's financial statements are interrelated, with each one affecting the others. For example, an increase in Phreesia's assets may result in an increase in income on the income statement.

Phreesia Stock Summary

Phreesia competes with Definitive Healthcare, HealthStream, Certara, National Research, and Health Catalyst. Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina. Phreesia operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 1701 people.
Foreign Associate
  Philippines
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINUS71944F1066
CUSIP71944F106
LocationNew York; U.S.A
Business Address1521 Concord Pike,
SectorHealth Care Technology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.phreesia.com
Phone888 654 7473
CurrencyUSD - US Dollar

Phreesia Key Financial Ratios

Phreesia Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets158.8M326.7M494.5M370.1M370.3M288.6M
Other Current Liab21.6M33.1M43.2M42.9M68.0M37.6M
Net Tangible Assets91.7M241.8M353.2M254.1M292.2M306.8M
Net Debt(66.5M)(204.5M)(298.0M)(167.5M)(75.5M)(79.3M)
Retained Earnings(284.5M)(311.8M)(429.9M)(606.1M)(743.0M)(705.8M)
Accounts Payable6.0M4.4M5.1M10.8M8.5M6.5M
Cash90.3M218.8M313.8M176.7M87.5M141.3M
Other Assets2.5M3.6M7.1M5.1M1.00.95
Long Term Debt19.4M6.5M139K2.7M2.0M1.9M
Net Receivables22.0M29.1M40.3M51.4M64.9M37.1M
Good Will250K8.3M33.6M33.7M75.8M79.6M
Long Term Debt Total21.5M6.5M7.4M2.7M2.5M2.3M
Capital Surpluse386.4M579.6M860.7M927.0M1.1B1.1B
Inventory6.9M8.9M1.6M1.1M768K729.6K
Other Current Assets12.4M22.7M30.6M33.3M42.5M26.2M
Total Liab56.9M63.4M77.2M82.2M118.9M102.1M
Net Invested Capital121.3M274.6M417.3M295.7M254.6M162.4M
Short Long Term Debt2.3M4.9M5.8M5.2M1.1M1.0M
Total Current Assets131.5M272.3M386.3M262.4M195.7M207.0M
Treasury Stock(399K)(5.0M)(14.0M)(33.6M)(30.2M)(28.7M)
Cash And Equivalents90.3M218.8M313.8M176.7M203.2M148.8M
Net Working Capital96.2M217.3M317.9M183.4M85.6M144.0M

Phreesia Key Income Statement Accounts

The reason investors look at the income statement is to determine what Phreesia's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201920202021202220232024 (projected)
Tax Provision(1.8M)49K182K483K1.5M1.6M
Net Interest Income(2.4M)(1.6M)(1.1M)1.1M2.2M2.3M
Interest Income2.4M1.6M1.1M1.1M4.1M4.3M
Interest Expense2.4M1.7M1.2M1.4M1.9M1.8M
Total Revenue124.8M148.7M213.2M280.9M356.3M204.9M
Gross Profit80.1M96.3M131.8M171.6M201.7M124.9M
Operating Income(12.0M)(25.7M)(116.8M)(176.6M)(131.8M)(125.2M)
Ebit(12.0M)(25.5M)(116.8M)(174.3M)(133.5M)(126.8M)
Research Development18.6M22.6M52.3M91.2M112.3M118.0M
Ebitda1.9M(7.6M)(92.3M)(145.5M)(102.9M)(97.8M)
Cost Of Revenue44.7M52.4M81.4M109.3M154.6M80.0M
Income Before Tax(22.1M)(27.2M)(118.0M)(175.7M)(135.3M)(128.6M)
Net Income(20.3M)(27.3M)(118.2M)(176.1M)(136.9M)(130.0M)
Income Tax Expense(1.8M)49K182K483K1.5M1.6M

Phreesia Key Cash Accounts

201920202021202220232024 (projected)
Investments(12.3M)(25.1M)(65.2M)(26.2M)(39.7M)(41.7M)
Change In Cash88.8M128.5M95.0M(137.1M)(89.2M)(84.7M)
Net Borrowings(10.7M)(23.0M)(5.3M)(613K)(551.7K)(579.3K)
Free Cash Flow(11.5M)(15.7M)(105.5M)(116.3M)(57.5M)(60.3M)
Depreciation13.9M15.9M21.3M25.3M29.5M20.0M
Other Non Cash Items7.5M4.9M4.4M5.4M4.8M4.8M
Capital Expenditures12.3M18.6M30.8M26.2M25.1M21.2M
Net Income(20.3M)(27.3M)(118.2M)(176.1M)(136.9M)(130.0M)
End Period Cash Flow90.3M218.8M313.8M176.7M87.5M141.3M
Change To Netincome10.5M16.0M38.2M59.2M68.1M71.5M

Phreesia Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Phreesia's current stock value. Our valuation model uses many indicators to compare Phreesia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Phreesia competition to find correlations between indicators driving Phreesia's intrinsic value. More Info.
Phreesia is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Phreesia's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Phreesia by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Phreesia Systematic Risk

Phreesia's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Phreesia volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Phreesia correlated with the market. If Beta is less than 0 Phreesia generally moves in the opposite direction as compared to the market. If Phreesia Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Phreesia is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Phreesia is generally in the same direction as the market. If Beta > 1 Phreesia moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Phreesia Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Phreesia's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Phreesia growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.67

At this time, Phreesia's Price Earnings To Growth Ratio is relatively stable compared to the past year.

Phreesia November 22, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Phreesia help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Phreesia. We use our internally-developed statistical techniques to arrive at the intrinsic value of Phreesia based on widely used predictive technical indicators. In general, we focus on analyzing Phreesia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Phreesia's daily price indicators and compare them against related drivers.

Additional Tools for Phreesia Stock Analysis

When running Phreesia's price analysis, check to measure Phreesia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phreesia is operating at the current time. Most of Phreesia's value examination focuses on studying past and present price action to predict the probability of Phreesia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phreesia's price. Additionally, you may evaluate how the addition of Phreesia to your portfolios can decrease your overall portfolio volatility.